$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
What diseases does Imatinib (Gleevec) mainly treat and its indications?
2026-02-01 22:25:32
Check Details
An introduction to the expected domestic launch time and approval progress of ruxolitinib cream (Opzelura)
2026-02-01 22:25:32
Check Details
Differences between domestic and imported Jisandai (Epclusa) drugs, as well as price and efficacy comparisons
2026-02-01 22:25:32
Check Details
Sunitinib regular purchase channels and online pharmacy reference
2026-02-01 22:25:32
Check Details
Analysis on whether tazetostat (Daveco) needs to be taken continuously for a long time
2026-02-01 22:25:32
Check Details
Analysis of detailed indications and applicable patient groups of ceritinib/ceritinib (Zanda)
2026-02-01 22:25:32
Check Details
An analysis of whether Bestifan (Viliru) can be used in combination with other anti-tumor drugs
2026-02-01 22:25:32
Check Details
Analysis of the main indications and clinical users of dabrafenib (Tefila)
2026-02-01 22:25:32
Check Details
Is there a domestic version of Axitinib and the latest news on domestic research and development progress?
2026-02-01 22:25:32
Check Details
How to adjust the dosage of Trametinib (Megenin) and reference for patients with different weights
2026-02-01 22:25:32
Check Details
What is avatrombopag (Su Kexin) and its treatment principle explanation
2026-02-01 22:25:32
Check Details
Is there any generic version of Gilteritinib and its market price comparison?
2026-02-01 22:25:32
Check Details
1
2
...
2073
2074
2075
2076
2077
2078
2079
...
10226
10227
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
SCEMBLIX (Asciminib) Side Effect Management & Special Population Guide
2
Sabril (Vigabatrin) Explained: Indications, Vision Loss Risk & Key Warnings
3
FDA Approves Tauklarify for Tau PET Imaging in Alzheimer's Disease Assessment
4
First CELMoD Drug Zenbexus Wins FDA Accelerated Approval for Multiple Myeloma
5
Elamipretide Side Effects and Medication Safety Guide: Injection Site Reactions and Storage Essentials
6
Dutasteride Soft Capsules: Comprehensive Side Effect Profile and Management Strategies
7
Oral Semaglutide Tablets: A Complete Guide to the GLP-1 Receptor Agonist for Type 2 Diabetes and Cardiovascular Protection
8
Sotorasib (Lumakras): A Comprehensive Guide to the First KRAS G12C-Targeted Inhibitor
9
Comprehensive Interpretation of Osimertinib: Efficacy, Side Effects and Medication Standards
10
Sotorasib: Can the First KRAS G12C-Targeted Therapy Cure Cancer?
11
Trametinib (Mekinist): Refrigerated Storage, Fasting Administration, and BRAF Mutation Indications Explained
12
Asciminib (SCEMBLIX): STAMP Inhibitor Dosing Guide and Nomenclature Clarification for CML